These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31147315)

  • 1. Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.
    Kapelyukh Y; Henderson CJ; Scheer N; Rode A; Wolf CR
    Drug Metab Dispos; 2019 Aug; 47(8):907-918. PubMed ID: 31147315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.
    Stiborová M; Levová K; Bárta F; Shi Z; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Arlt VM
    Toxicol Sci; 2012 Feb; 125(2):345-58. PubMed ID: 22086975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.
    Uno S; Endo K; Ishida Y; Tateno C; Makishima M; Yoshizato K; Nebert DW
    Toxicol Appl Pharmacol; 2009 May; 237(1):119-26. PubMed ID: 19285097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice.
    Derkenne S; Curran CP; Shertzer HG; Dalton TP; Dragin N; Nebert DW
    Pharmacogenet Genomics; 2005 Jul; 15(7):503-11. PubMed ID: 15970798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line.
    Dragin N; Uno S; Wang B; Dalton TP; Nebert DW
    Biochem Biophys Res Commun; 2007 Aug; 359(3):635-42. PubMed ID: 17560947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I.
    Levova K; Moserova M; Nebert DW; Phillips DH; Frei E; Schmeiser HH; Arlt VM; Stiborova M
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):360-7. PubMed ID: 22982977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regulation of hepatic and pulmonary mouse CYP1A1 expression and augmented human CYP1A1 transcriptional activation in response to 3-methylcholanthrene in vivo.
    Jiang W; Wang L; Kondraganti SR; Fazili IS; Couroucli XI; Felix EA; Moorthy B
    J Pharmacol Exp Ther; 2010 Nov; 335(2):369-79. PubMed ID: 20732958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.
    Spatzenegger M; Horsmans Y; Verbeeck RK
    Pharmacol Toxicol; 2000 Feb; 86(2):71-7. PubMed ID: 10728918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2?
    Liu N; Zhang QY; Vakharia D; Dunbar D; Kaminsky LS
    Arch Biochem Biophys; 2001 May; 389(1):130-4. PubMed ID: 11370663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential.
    Dragin N; Dalton TP; Miller ML; Shertzer HG; Nebert DW
    J Biol Chem; 2006 Jul; 281(27):18591-600. PubMed ID: 16636061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2.
    Mahajan SS; Rifkind AB
    Toxicol Appl Pharmacol; 1999 Feb; 155(1):96-106. PubMed ID: 10036222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional cytochrome P450 1A enzymes are induced in mouse and human islets following pollutant exposure.
    Ibrahim M; MacFarlane EM; Matteo G; Hoyeck MP; Rick KRC; Farokhi S; Copley CM; O'Dwyer S; Bruin JE
    Diabetologia; 2020 Jan; 63(1):162-178. PubMed ID: 31776611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A.
    Lingappan K; Jiang W; Wang L; Couroucli XI; Moorthy B
    Toxicology; 2015 May; 331():14-23. PubMed ID: 25703676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2.
    Cheung C; Ma X; Krausz KW; Kimura S; Feigenbaum L; Dalton TP; Nebert DW; Idle JR; Gonzalez FJ
    Chem Res Toxicol; 2005 Sep; 18(9):1471-8. PubMed ID: 16167840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine.
    Ching MS; Blake CL; Malek NA; Angus PW; Ghabrial H
    Xenobiotica; 2001 Nov; 31(11):757-67. PubMed ID: 11765139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.
    Kondraganti SR; Jiang W; Moorthy B
    J Pharmacol Exp Ther; 2002 Dec; 303(3):945-51. PubMed ID: 12438513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity.
    Casley WL; Menzies JA; Mousseau N; Girard M; Moon TW; Whitehouse LW
    Pharmacogenetics; 1997 Aug; 7(4):283-93. PubMed ID: 9295056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
    Jiang Z; Dalton TP; Jin L; Wang B; Tsuneoka Y; Shertzer HG; Deka R; Nebert DW
    Hum Mutat; 2005 Feb; 25(2):196-206. PubMed ID: 15643613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing and characterization of mixed function monooxygenase genes CYP1A1 and CYP1A2 of Mink (Mustela vison) to facilitate study of dioxin-like compounds.
    Zhang X; Moore JN; Newsted JL; Hecker M; Zwiernik MJ; Jones PD; Bursian SJ; Giesy JP
    Toxicol Appl Pharmacol; 2009 Feb; 234(3):306-13. PubMed ID: 19041884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.